Skip to main content
. 2022 Sep 28;13:965905. doi: 10.3389/fimmu.2022.965905

Figure 3.

Figure 3

mRMR analysis: MBLhi vs. CLL. (A) Distribution and classification of MBLhi and CLL patients from quantitative soluble immune checkpoints and cytokines in serum. (B) Boxplot sCD47 in serum between MBLhi and CLL (*pvalue< 0.05).